ME3 Biomarkers for fibrotic lung disease – new clinical benchmarks from the lab?

Meet the expert
Chairs:
Aims: The aims of the seminar are to provide the biological background of new candidate biomarkers, the potential clinical role as well as practical issues of obtaining appropriate samples for analysis.
HERMES LINKS
ADULT: B.7 Diffuse parenchymal (interstitial) lung diseases.

Educational Material

Handout ME3
Open

Reading list ME3
Open

Download all media

Biomarkers for fibrotic lung disease - new clinical benchmarks from the lab? M. Kolb (Hamilton, Canada)